S&P Global Market Intelligence: FDA Orange Book

The FDA Orange Book identifies drug products approved on the basis of safety and effectiveness by the FDA.

Description:

FDA Orange Book is one of three datasets offered by S&P Global Market Intelligence from the U.S. Food and Drug Administration (FDA). The FDA Orange Book identifies drug products approved on the basis of safety and effectiveness by the FDA. Relates a named drug to a set of compounds and to the drug owner.

Dataset Overview:

Primary Entity Type: Company
Coverage Count: 50,000
Geographic Coverage: United States and Canada
Industry Coverage: Healthcare
History Initiated: 2001
Data Source: FDA.gov

About the Provider:

Your source for premium financial and alternative datasets. With the goal to source, structure, link, and deliver best-in-class data, you’re armed with differentiated and clean data to uncover insights that drive your business forward and make decisions with conviction.

Visit the provider’s website for more

Get access to S&P Global Market Intelligence: FDA Orange Book Dataset in Snowflake

Sign up for a free trial

Already a Snowflake customer?
Access this dataset directly from your Snowflake account